# Compass Therapeutics, Inc.: Form 8-K, filed Jun 23, 2026

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2026-06-23
- Accepted by EDGAR: Jun 22, 2026, 17:45 ET
- Period: 2026-06-22
- Accession: 0001171843-26-004224
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184326004224/f8k_062226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184326004224/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184326004224/f8k_062226.htm

Filed Jun 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004224. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
